Price T Rowe Associates Inc Inotiv, Inc. Transaction History

Price T Rowe Associates Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$9.81 - $26.17 $144,726 - $386,086	14,753 New	14,753 $249,000
Q1 2022 May 16, 2022	SELL	$18.52 - $40.41 $112,823 - $246,177	-6,092 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$30.55 - $57.88 $55,937 - $105,978	-1,831 Reduced 23.11%	6,092 $256,000
Q3 2021 Nov 15, 2021	SELL	$23.69 - $49.93 $2,369 - $4,993	-100 Reduced 1.25%	7,923 $232,000
Q2 2021 Aug 16, 2021	BUY	$18.9 - $31.42 $151,634 - $252,082	8,023 New	8,023 $214,000

10.3M

388K

145K

Ticker NOTV
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 25,594,500
Market Cap $104M
Description
Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segme...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.